Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

STEPHANIE ANN PRATHER

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1336758846
CMS profile
10470506
Location
MINDEN, NV

General Payments · PY2022–2024

$1,181.38

  • Reported across 86 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$636.87

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $636.87 37

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $217.07 20
ABBVIE INC. $169.77 8
Acerta Pharma LLC $136.78 3
Astellas Pharma US Inc $24.72 1
Bayer HealthCare Pharmaceuticals Inc. $22.75 1
PFIZER INC. $19.37 1
ITI, Inc. $16.11 1
Merck Sharp & Dohme Corporation $15.89 1
Amgen Inc. $14.41 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $206.37 23
PY2023 $338.14 26
PY2024 $636.87 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $17.35 02/07/2024 Food and Beverage Undisputed 01/23/2026 1108036784 CMS
ABBVIE INC. $17.83 02/29/2024 Food and Beverage Undisputed 01/23/2026 1108036786 CMS
ABBVIE INC. $27.10 04/10/2024 Food and Beverage Undisputed 01/23/2026 1108036788 CMS
ABBVIE INC. $21.72 06/05/2024 Food and Beverage Undisputed 01/23/2026 1108036790 CMS
ABBVIE INC. $19.81 07/10/2024 Food and Beverage Undisputed 01/23/2026 1108036792 CMS
ABBVIE INC. $24.30 07/30/2024 Food and Beverage Undisputed 01/23/2026 1108036794 CMS
ABBVIE INC. $21.03 08/14/2024 Food and Beverage Undisputed 01/23/2026 1108036796 CMS
ABBVIE INC. $20.63 10/16/2024 Food and Beverage Undisputed 01/23/2026 1108036798 CMS
Amgen Inc. $14.41 10/08/2024 Food and Beverage Undisputed 01/23/2026 1117658856 CMS
Astellas Pharma US Inc $24.72 03/13/2024 Food and Beverage Undisputed 01/23/2026 1139477736 CMS
AstraZeneca Pharmaceuticals LP $14.55 01/17/2024 Food and Beverage Undisputed 01/23/2026 1104550476 CMS
AstraZeneca Pharmaceuticals LP $106.33 03/14/2024 Food and Beverage Undisputed 01/23/2026 1105488085 CMS
AstraZeneca Pharmaceuticals LP $15.90 06/12/2024 Food and Beverage Undisputed 01/23/2026 1105555768 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.75 06/19/2024 Food and Beverage Undisputed 01/23/2026 1086327833 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.11 10/29/2024 Food and Beverage Undisputed 01/23/2026 1143584958 CMS
Merck Sharp & Dohme LLC $15.89 01/03/2024 Food and Beverage Undisputed 01/23/2026 1141982475 CMS
Novo Nordisk Inc $10.96 01/09/2024 Food and Beverage Undisputed 01/23/2026 1100378891 CMS
Novo Nordisk Inc $11.36 02/06/2024 Food and Beverage Undisputed 01/23/2026 1100626056 CMS
Novo Nordisk Inc $11.22 02/20/2024 Food and Beverage Undisputed 01/23/2026 1100437751 CMS
Novo Nordisk Inc $10.38 03/19/2024 Food and Beverage Undisputed 01/23/2026 1100546546 CMS
Novo Nordisk Inc $10.82 04/30/2024 Food and Beverage Undisputed 01/23/2026 1100530391 CMS
Novo Nordisk Inc $10.56 05/14/2024 Food and Beverage Undisputed 01/23/2026 1100510943 CMS
Novo Nordisk Inc $12.68 05/28/2024 Food and Beverage Undisputed 01/23/2026 1100561397 CMS
Novo Nordisk Inc $8.71 06/11/2024 Food and Beverage Undisputed 01/23/2026 1100366341 CMS
Novo Nordisk Inc $8.94 06/25/2024 Food and Beverage Undisputed 01/23/2026 1100381653 CMS
Novo Nordisk Inc $11.64 07/09/2024 Food and Beverage Undisputed 01/23/2026 1100294552 CMS
Novo Nordisk Inc $11.63 08/06/2024 Food and Beverage Undisputed 01/23/2026 1100237472 CMS
Novo Nordisk Inc $10.77 08/20/2024 Food and Beverage Undisputed 01/23/2026 1100374613 CMS
Novo Nordisk Inc $10.51 09/03/2024 Food and Beverage Undisputed 01/23/2026 1100311877 CMS
Novo Nordisk Inc $10.62 09/17/2024 Food and Beverage Undisputed 01/23/2026 1100338657 CMS
Novo Nordisk Inc $9.95 10/01/2024 Food and Beverage Undisputed 01/23/2026 1100568272 CMS
Novo Nordisk Inc $11.51 10/15/2024 Food and Beverage Undisputed 01/23/2026 1100566872 CMS
Novo Nordisk Inc $11.24 10/30/2024 Food and Beverage Undisputed 01/23/2026 1100553957 CMS
Novo Nordisk Inc $11.59 11/12/2024 Food and Beverage Undisputed 01/23/2026 1100500993 CMS
Novo Nordisk Inc $11.16 11/26/2024 Food and Beverage Undisputed 01/23/2026 1100487865 CMS
Novo Nordisk Inc $10.82 12/10/2024 Food and Beverage Undisputed 01/23/2026 1100333924 CMS
PFIZER INC. $19.37 12/03/2024 Food and Beverage Undisputed 01/23/2026 1131220383 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.